GamaMabs Pharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GamaMabs Pharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11305
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company that develops optimized therapeutic antibodies for the treatment of cancer. The company’s lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mullerian hormone (AMH) in gynecological cancers. It develops its products through EMABling, HuMabFc platforms, and others. GamaMabs’s products find therapeutic applications in the areas of ovarian and endometrium cancer among others. The company works in partnership with academic partners and other research centers such as Institut Gustave Roussy, Institut Curie, Institut Cochin, Institut de Recherche en Cancerologie de Montpellier and Mass General Hospital Boston. GamaMabs is headquartered at Toulouse, France.

GamaMabs Pharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GamaMabs Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
GamaMabs Pharma Raises USD16 Million in Series B Financing 10
GamaMabs Pharma Raises USD0.7 Million in Venture Financing 11
GamaMabs Pharma Raises USD5 Million in Series A Financing 12
GamaMabs Pharma Raises US$4.2 Million In Seed Financing 13
Partnerships 14
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 14
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 15
Licensing Agreements 16
GamaMabs Enters into Licensing Agreement with MedImmune 16
GamaMabs Pharma SA – Key Competitors 17
GamaMabs Pharma SA – Key Employees 18
GamaMabs Pharma SA – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Key Facts 2
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GamaMabs Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GamaMabs Pharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GamaMabs Pharma Raises USD16 Million in Series B Financing 10
GamaMabs Pharma Raises USD0.7 Million in Venture Financing 11
GamaMabs Pharma Raises USD5 Million in Series A Financing 12
GamaMabs Pharma Raises US$4.2 Million In Seed Financing 13
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 14
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 15
GamaMabs Enters into Licensing Agreement with MedImmune 16
GamaMabs Pharma SA, Key Competitors 17
GamaMabs Pharma SA, Key Employees 18

List of Figures
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GamaMabs Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GamaMabs Pharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gilead Sciences, Inc.:戦略・SWOT・企業財務分析
    Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • Victoria PLC (VCP):企業の財務・戦略的SWOT分析
    Victoria PLC (VCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務分析
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Mercury NZ Ltd:発電所・企業SWOT分析
    Mercury NZ Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Compania Espanola de Petroleos SAU:石油・ガス:M&Aディール及び事業提携情報
    Summary Compania Espanola de Petroleos SAU (CEPSA) is an integrated energy company. It explores for, produces, refines, transports, and markets and sells crude oil, petroleum products, and natural gas. The company also generates and sells electricity and thermal power to industrial customers and con …
  • MAN SE (MAN)-エネルギー分野:企業M&A・提携分析
    Summary MAN SE (MAN) is a commercial vehicle and mechanical engineering company. It involves in designing, developing, manufacture and sale of wide range of engineering goods such as trucks, buses, diesel engines, turbo machinery, and special gear systems. The company operates production facilities …
  • PolyNovo Ltd (PNV):企業の財務・戦略的SWOT分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, designs, develops and manufactures dermal regeneration solutions for various medical applications. The company offers NovoSorb BTM (Biodegradable Temporising Matrix), a synthetic, biodegradable and biocompatible device that facilitates the growt …
  • Taubman Centers Inc (TCO):企業の財務・戦略的SWOT分析
    Taubman Centers Inc (TCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SGS SA (SGSN):企業の財務・戦略的SWOT分析
    SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Welch Allyn Inc:企業の戦略的SWOT分析
    Welch Allyn Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Husqvarna AB (HUSQ B):企業の財務・戦略的SWOT分析
    Summary Husqvarna AB (Husqvarna) is an industrial equipment company. The company produces outdoor power products for forestry, gardening and construction. It offers wheeled products, electric products. Husqvarna also provides handheld products, watering and hand tools, accessories, and construction …
  • Indiana University Research & Technology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Indiana University Research & Technology Corp (IURTC), a subsidiary of Indiana University, is a non-profit company that handles intellectual property, trademarks, and business development activities. The company offers solutions such as technology commercialization, which include disclosure, …
  • New York Blood Center:製薬・医療:M&Aディール及び事業提携情報
    Summary New York Blood Center (NYBC) is a non-profit healthcare organization that offers blood collection and distribution. The organization's blood products comprise red blood cells, plasma products, platelets, frozen blood and washed products, whole blood and granulocytes. It offers medical servic …
  • Neuwave Medical Inc-医療機器分野:企業M&A・提携分析
    Summary NeuWave Medical Inc (NeuWave), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. Its flagship product, Certus 140 microwave ablation (coagulation) system, is a minimally invasive soft tissue ablation s …
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Power Engineering Consulting 1 Joint Stock Company (TV1):企業の財務・戦略的SWOT分析
    Summary Power Engineering Consulting Joint Stock Company 1 (PECC1), formerly Power Engineering Consulting Company 1, a subsidiary of Vietnam Electricity, is a power company that offers engineering consulting services. The company offers engineering advisory services such as construction, design, fea …
  • Tribune Media Company:企業の戦略・SWOT・財務情報
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NorthWestern Corp (NWE):石油・ガス:M&Aディール及び事業提携情報
    Summary NorthWestern Corp, doing business as NorthWestern Energy, is an electric and natural gas utility. It generates, transmits, and electricity, and also carries out mid-stream operations. The company produces from wind, hydro, solar, coal, and natural gas. NorthWestern Energy produces, stores, t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆